Adalimumab 80mg/0.8mL
- Brand Names: Humira, Amjevita, Imraldi, Cyltezo, Hyrimoz, Hulio, Hadlima, Abrilada, Cadalimab, Idacio, Simlandi
- Form: PFS, Vial for subcutaneous injection (solution)
- Strength: 80 mg/0.8 mL
- Manufacturer: AbbVie (Humira); Biosimilars by Amgen, Samsung Bioepis, Sandoz, Boehringer Ingelheim, Cadila (Cadalimab), Torrent
- Country: US, India, Canada, Mexico
- MOQ: 5 units
- Shelf Life: 24 Months
- Storage: 2–8 °C; protect from light; do not freeze
Description
Indications & Usage: Adalimumab is a fully human anti‑TNFα monoclonal antibody used for rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, plaque psoriasis, Crohn’s disease, ulcerative colitis, hidradenitis suppurativa, juvenile idiopathic arthritis, and uveitis. The medication works by binding TNFα, reducing inflammation and immune‑mediated tissue damage.
